We provide two alternatives for this step, depending on the backbone used for cloning: Version A allows cloning into CRISPR vectors with BbsI (BpiI) sites (such as pX458); and Version B allows cloning into CRISPR vectors with BsmBI (Esp3I) sites (such as lentiCRISPR v2).
1. Guide RNA design
a) Identify the target sequence for deletion. Any genomic loci flanked by two SpCas9 PAM sequence (NGG) may be targeted.
b) Design SpCas9 sgRNAs (17-20 nt protospacers) with Cas-Designer, or another computational tool.
VERSION A (BbsI/Bpi)
c) Synthesise oligonucleotides according to the following logic: Forward oligo = 5’CGAGAAGACCTCACCGNNNNNNNNNNNNNNNNNNNNGTTTTAGAGCTAGAAATAGCAA-3’, where N corresponds to your protospacer sequence; Reverse Oligo = 5’GGTGAAGACCCAAACNNNNNNNNNNNNNNNNNNNNGGGAAAGAGTGGTCTCA-3’, where N corresponds to the reverse complement of your protospacer sequence (see also Figure 1b). A template for generation of oligo sequences for ordering is provided in "Template for oligo design for dual cloning into BbsI (BpiI) vectors.xlsx" (see Supplementary Files).
VERSION B (BsmBI/Esp3I)
c) Synthesise oligonucleotides according to the following logic: Forward oligo = 5'ACCGTCTCTCACCGNNNNNNNNNNNNNNNNNNNNGTTTTAGAGCTAGAAATAGCAA-3', where N corresponds to your protospacer sequence; Reverse Oligo = 5'CCCGTCTCCAAACNNNNNNNNNNNNNNNNNNNNGGGAAAGAGTGGTCTCA-3', where N corresponds to the reverse complement of your protospacer sequence (see also Figure 1c). A template for generation of oligo sequences for ordering is provided in "Template for oligo design for dual cloning into BsmBI (Esp3I) vectors.xlsx" (see Supplementary Files).
d) Request oligonucleotide synthesis from commercial vendor. DST-grade oligos are enough for this application.
2. Coupling of guide RNA pair by PCR
a) Prepare the following reaction mix:
4 μL of Q5 Buffer
0.4 μL of 10mM dNTPs
1 μL of 10μM Forward Primer (containing gRNA #1)
1 μL of 10μM Reverse Primer (containing gRNA #2)
0.2 μL of Q5 High-Fidelity DNA Polymerase
1 μL of pScaffold-H1 (1 ng/μL)
13.4 μL Nuclease-Free Water
Total volume = 20 μL
b) Thermal cycler conditions: 98°C for 30 sec, 30 cycles of (98°C for 10s, 58°C for 15s, 72°C for 15s), hold at 12°C.
c) Check PCR product by 1.5% agarose gel electrophoresis. The PCR should yield as clear band of 353 bp (see Figure 2).
d) Purify PCR product with QIAquick PCR Purification Kit.
e) Dilute to 10 ng/µL in Nuclease-Free Water.
Technical note: The cohesive ends generated by the BbsI/BpiI and the BsmbI/Esp3I enzymes are identical. Therefore, primers containing a different restriction site than the vector (e.g. BbsI primers and BsmBI vector) can be used to clone the pair of guide RNAs in this vector using an additional digestion step. This allowed the repurposing of a single pair of primers for both types of vector. The additional step is performed after step 2d. 500 ng of the purified PCR product is digested following the same procedure as step 3 with the restriction enzyme corresponding to the primer used, omitting the vector, ATP and T7 ligase and incubated 1h at 37ºC. The digested product is purified using QIAquick PCR Purification Kit and diluted at 10 ng/µL. The protocol can then be continued at step 3 using the protocol corresponding of the vector’s restriction sites.
3. Single-step digestion-ligation reaction
VERSION A (BbsI/Bpi)
a) Ligate the amplified PCR product containing a pair of guide RNAs into your desired vector as follows:
2 μL of 10X Tango buffer
1 μL of pX458 vector or similar (100 ng/μL)
1 μL of PCR product (10 ng/µL)
1 μL of 0.1M DTT
1 μL of FastDigest BpiI
1 μL of 10mM ATP
0.5 μL T7 Ligase
12.5 μL Nuclease-Free Water
Total volume = 20 μl
b) Thermal cycler conditions: 6 cycles of (37°C for 5 min, 23 for 5 min), 37°C for 10 min, hold at 4°C.
VERSION B (BsmBI/Esp3I)
a) Ligate the amplified PCR product containing a pair of guide RNAs into your desired vector as follows:
2 μL of 10X Esp3I Fast Digest Buffer
1 μL of lentiCRISPR v2 vector or similar (100 ng/μL)
1 μL of PCR product (10 ng/µL)
0.2 μL of 0.1M DTT
1 μL of FastDigest Esp3I
2 μL of 10mM ATP
0.5 μL T7 Ligase
12.3 μL Nuclease-Free Water
Total volume = 20 μL
b) Thermal cycler conditions: 6 cycles of (37°C for 5 min, 23 for 5 min), 37°C for 10 min, hold at 4°C.
Technical note 1: Depending on the vector used, a different restriction enzyme will be needed for this step. Vectors commonly used for CRISPR/Cas9 experiments with plasmid transfection such as pX458 contain BbsI (BpiI) sites. While for lentiviral-based experiments, backbones such as the lentiCRISPR v2 contain BsmBI (Esp3I) sites.
Technical note 2: In this protocol we suggest using a high-fidelity DNA polymerase. While we wrote the protocol with Q5, other high fidelity polymerases should work equally well. If changing polymerase, we advise optimising the cycling conditions following manufacturer's instructions.
4. Transformation into chemically competent bacteria
a) Thaw competent cells on ice
b) Add 2 μL of the ligation into the tube with 50 μL of competent cells and mix very gently. Do not vortex.
c) Incubate on ice for 30 minutes.
d) Heat-shock the cells for 30 seconds at 42°C in a water bath.
e) Remove the vial from the water bath and place it on ice for 2 minutes.
f) Add 250 μL of pre-warmed S.O.C. Medium to the vial.
g) Shake horizontally at 37°C for 1 hour at 225 rpm in a shaking incubator.
h) Spread 50 μL from the transformation mix on a pre-warmed LB-agar plate with appropriate antibiotic resistance.
i) Invert the selective plate (100 µg/mL) and incubate at 37°C overnight.
Technical note 1: We routinely use 1 μL of ligation with 10-15 μL of competent cells per transformation, which still yields a good number of colonies after plating.
Technical note 2: We strongly advice using an E. coli strain suitable for cloning unstable DNA constructs (e.g. RecA, RecA1, or RecA13 strain), such as One Shot Stbl3 Chemically Competent E. coli (Invitrogen) or NEB Stable (New England Biolabs).
5. Confirmation of successful cloning
The pScaffold-H1 vector used as PCR template contains a Kanamycin resistance cassette and the most commonly used CRISPR vectors contain a Ampicillin resistance cassette. Therefore, after transformation and spreading onto LB-agar plates with ampicillin, we do not detect colonies containing the pScaffold-H1 vector.
Using this protocol, we usually observe an efficiency of >95% for most backbones, for this reason, we do not perform colony PCR to screen for positive colonies ahead of sequencing.
a) Pick one colony from the plate and inoculate 2 mL of LB Broth.
b) Incubate overnight at 225 rpm in an orbital shaking incubator.
c) The next day, analyse by plasmid isolation with a miniprep kit, followed by Sanger sequencing using primer LKO or U6.